Duren Health Mart Pharmacy Recalls Omeprazole Suspension Due to Processing Controls
Duren Health Mart Pharmacy is recalling Omeprazole 4 mg/mL Suspension because of a lack of processing controls. The recall is limited to Tennessee.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Duren Health Mart Pharmacy is recalling Omeprazole 4 mg/mL Suspension, 150cc to 300 cc per prescription, Rx only. The recall is due to a lack of processing controls. The affected product is identified by NDC 00000-0001-07.
The recall is limited to Tennessee. The source text does not specify the exact number of units affected or the specific dates of distribution.
Consumers with this product should contact their healthcare provider or the pharmacy for instructions on how to proceed. The source text does not provide specific contact information for the recall.
The recalled product
- Product
- Omeprazole 4 mg/mL Suspension, 150cc to 300 cc per prescription, Rx only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN 38485, NDC 00000-0001-07
- Manufacturer
- Duren Health Mart Pharmacy
- Category
- Drug — Pharmacy Compounded
- Hazard
- Affected units
- 2,700
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- N/A
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 6 recalled by Duren Health Mart Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Duren Health Mart Pharmacy
See all →- ModerateTestosterone Cream Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- ModeratePromethazine Gel Recalled by Duren Health Mart Pharmacy for Processing Control Issues
FDA (Drugs) · 2019-02-06
- ModerateDomperidone 10 mg Capsules Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- ModerateProgesterone 100 mg SR Capsules Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- ModerateProgesterone Cream Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
Same hazard · processing controls
See all →- HighCompounded tirzepatide 8.8 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 11.24 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.22 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.44 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 4.4 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
Similar recalls
- ModerateNaltrexone Suspension Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateKremers Urban Recalls Omeprazole Capsules for Acid Resistance Failure
FDA (Drugs) · 2013-11-27
- ModerateKroger Specialty Pharmacy Recalls Dexamethasone Tablets Due to Processing Controls
FDA (Drugs) · 2018-05-16
- HighLansoprazole Suspension Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- ModerateAkorn Recalls Sulfamethoxazole and Trimethoprim Oral Suspension for Dissolution Failure
FDA (Drugs) · 2015-05-20
- ModerateNaltrexone Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22